- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.08. | PTC to Acquire Sangamo's Fabry Disease Gene Therapy | ||
| 12.08. | Perlen Packaging Expands into Pharma Bottles Market | ||
| 12.08. | Acelot Appoints Mark Forman as Chief Development Officer & Chief Medical Officer | ||
| 12.08. | Sentynl Secures U.S. Rights to Mereo's Alvelestat | ||
| 12.08. | Astorg Acquires Thermo Fisher Microbiology Business for $1.075B | ||
| 11.08. | CPHI Milan 2026 Launches Four New Specialist Zones | ||
| 11.08. | CPHI Unveils Pharma Sustainability Summit | ||
| 11.08. | ILiAD Appoints Former GSK Exec as Chief Business Officer | ||
| 11.08. | Altasciences Expands Bioanalytical Labs in North America | ||
| 11.08. | Cambrex Breaks Ground on $30M Milan R&D Facility | ||
| 10.08. | BMS to Build $2.3B Manufacturing Campus in Houston | ||
| 10.08. | Bruker Invests in Organ-on-a-Chip Firm Mimetas | ||
| 10.08. | Scinai Appoints Eran Kuratz as Head of Supply Chain & Business Process Administration | ||
| 10.08. | Innovent Adds Vanflyta to China Oncology Portfolio | ||
| 07.08. | Jones Healthcare Group Acquires Ontario Thermoforming Facility | ||
| 07.08. | Biogen Completes RayThera Acquisition | ||
| 07.08. | AstraZeneca, CSPC Establish New Biologics Manufacturing JV in China | ||
| 06.08. | Mediar and Ono to Develop Novel Treatments Targeting Fibro-Inflammatory Diseases | ||
| 06.08. | CellFiber, Tidewave Bio to Evaluate 3D Cell Culture Platform for Scalable Manufacturing | ||
| 06.08. | Evotec, Odyssey Launch R&D Partnership in Autoimmune, Inflammatory Diseases | ||
| 06.08. | ILC Dover Shares Testing Results for EZJetFlo for Powder Dissolution and Mixing | ||
| 05.08. | BMS to Deploy Schrödinger AI Co-Scientist Bunsen in Its Research Organization | ||
| 05.08. | Porton Advanced Expands CDMO Services to Commercialization with China Manufacturing License | ||
| 05.08. | NueCell Bio Launches as Specialist Partner in Cell Therapy Acceleration | ||
| 05.08. | Alteogen Inks Licensing Pact with Global Pharma Company to Develop, Commercialize Subcutaneous Biologic |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.